(Q35172006)

6 August 2017

title

Antiphospholipid syndrome: pathogenic mechanisms (English)

1 reference

antiphospholipid syndrome

6 August 2017

main subject

1 reference

4

Yehuda Shoenfeld

1 reference

6 August 2017

Ricard Cervera i Segura

series ordinal

2

object named as

Ricard Cervera

1 reference

6 August 2017

1

Gerard Espinosa

1 reference

6 August 2017

3

Josep Font

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

86-93

1 reference

Guidelines on the investigation and management of the antiphospholipid syndrome

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Immunology of the antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Mechanisms of autoantibody-mediated thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Autoantibodies directed against the epidermal growth factor‐like domains of thrombomodulin inhibit protein C activation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Annexin V is critical in the maintenance of murine placental integrity

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Effects of β2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900144-1

7 January 2021

10.1016/S1568-9972(02)00144-1

Identifiers

DOI

1 reference

release_3ewvryjoy5fj3idzmi3puzcvpi

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3ewvryjoy5fj3idzmi3puzcvpi

24 November 2022

mapped directly with Wikidata item

1 reference